Expression of carcinoma, apoptosis, and cell‐death–related genes are determinants for sensitivity of pediatric cancer cell lines to lysis by natural killer cells-Reference-Cited by-同舟云学术

Expression of carcinoma, apoptosis, and cell‐death–related genes are determinants for sensitivity of pediatric cancer cell lines to lysis by natural killer cells

Published:2019-07-15 Issue: Volume: Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Ray Anish K.¹^ORCID,Somanchi Srinivas S.²,Dastgheyb Neda²,Lopez Arianexys Aquino²,Cobanoglu Zehra E.²,Geier Brian³,Lee Dean A.³^ORCID

Affiliation:

1. Department of Hematology/OncologyCook Children's Hospital Fort Worth Texas

2. Department of Pediatrics ResearchThe University of Texas MD Anderson Cancer Center Houston Texas

3. Center for Childhood Cancer and Blood DiseasesNationwide Children's Hospital Columbus Ohio

Funder

St. Baldrick's Foundation

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.27783

Reference52 articles.

1. Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

2. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

3. Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy

4. Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells

5. Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic Fc-active TIGIT antibodies;Journal for ImmunoTherapy of Cancer;2023-12

2. Research Progress of Interleukins Regulating Biological Activity of NK Cells in Vitro;Advances in Clinical Medicine;2023

3. Evaluation of allogeneic and autologous membrane-bound IL-21–expanded NK cells for chronic lymphocytic leukemia therapy;Blood Advances;2022-10-18

4. Natural Killer Cell Recognition and Control of Epithelial Cancers;The Cancer Journal;2022-07

5. Approaches to Enhance Natural Killer Cell-Based Immunotherapy for Pediatric Solid Tumors;Cancers;2021-06-04